TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Leo Pharma AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 157,865 | 173,369 | 188,234 |
Financial expenses | 2,324 | 418 | 574 |
Earnings before taxes | 6,195 | 7,824 | 8,488 |
EBITDA | 6,546 | 8,302 | 8,878 |
Total assets | 132,245 | 208,845 | 101,865 |
Current assets | 124,311 | 193,707 | 86,642 |
Current liabilities | 81,858 | 97,831 | 52,697 |
Equity capital | 29,813 | 25,482 | 19,515 |
- share capital | 1,000 | 1,000 | 1,000 |
Employees (average) | 18 | 31 | 35 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 22.5% | 12.2% | 19.2% |
Turnover per employee | 8,770 | 5,593 | 5,378 |
Profit as a percentage of turnover | 3.9% | 4.5% | 4.5% |
Return on assets (ROA) | 6.4% | 3.9% | 8.9% |
Current ratio | 151.9% | 198.0% | 164.4% |
Return on equity (ROE) | 20.8% | 30.7% | 43.5% |
Change turnover | -15,504 | -14,865 | -11,347 |
Change turnover % | -9% | -8% | -6% |
Chg. No. of employees | -13 | -4 | 1 |
Chg. No. of employees % | -42% | -11% | 3% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.